Establishment Labs (ESTA) | Stock Overview & Key Data
Establishment Labs Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $93.80 on April 18, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Establishment Labs
ESTA
|
1.91B Small-cap | 12.52% | 28.06% | 32.66% | 16.91% | 22.33% | 119.39% | 25.90% | 5.07% | 211.25% | 211.25% | 211.25% |
| 160.70B Large-cap | -2.02% | 4.97% | -19.35% | -30.98% | -28.60% | -34.98% | -16.97% | -20.08% | 135.84% | 255.56% | 329.52% | |
|
Stryker
SYK
|
126.25B Large-cap | 2.13% | 0.38% | -11.91% | -13.33% | -11.56% | -17.25% | 6.06% | 22.47% | 172.95% | 440.98% | 592.85% |
|
Axogen
AXGN
|
1.94B Small-cap | 5.50% | 6.71% | 33.19% | 46.88% | 41.10% | 341.03% | 367.90% | 106.53% | 628.81% | 1,769.57% | 12,185.71% |
|
Artivion
AORT
|
1.83B Small-cap | 3.33% | -7.47% | -43.66% | -53.56% | -52.61% | -28.85% | 25.55% | -29.37% | 70.34% | 288.03% | 318.75% |
|
AdaptHealth
AHCO
|
1.73B Small-cap | 7.24% | 7.35% | -13.43% | 5.38% | 13.34% | 18.14% | 0.59% | -63.29% | 4.74% | 4.74% | 4.74% |
Ownership & Short Interest
Calculate Your Establishment Labs Investment Returns
Long-Term Investment Performance Analysis
Establishment Labs stock price in Jul 2018 was $26.39, A $1,000.00 lump sum investment in Establishment Labs made 7 years ago would be worth approximately $3,190.98 today, representing a outstanding return of 219.10%. This translates to an annualized return (CAGR) of 15.79%.
7 Years 10 Months Investment Scenario (Jul 2018 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is ESTA's 52-week high and low?
- In the last 52 weeks, Establishment Labs reached a high of $86.00 (on June 12, 2026) and a low of $33.35 (on August 12, 2025).
- What is the market cap and P/E ratio for ESTA?
- Curious about Establishment Labs's size and valuation? Its market capitalization stands at 1.91B. When it comes to valuation, the P/E ratio (trailing twelve months) is -37.89, and the forward P/E (looking ahead) is 316.35.
- Does ESTA pay dividends? If so, what's the yield?
- As for dividends, Establishment Labs isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Establishment Labs's main competitors or similar companies to consider before investing?
When looking at Establishment Labs, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT160.70B Healthcare Medical Devices -34.98% -16.97% Stryker
SYK126.25B Healthcare Medical Devices -17.25% 6.06% Axogen
AXGN1.94B Healthcare Medical Devices 341.03% 367.90% Artivion
AORT1.83B Healthcare Medical Devices -28.85% 25.55% AdaptHealth
AHCO1.73B Healthcare Medical Devices 18.14% 0.59% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Establishment Labs Holdings Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Establishment Labs's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -133.25%, the Debt to Equity ratio from the most recent quarter is 1,123.15, and its Gross Profit Margin stands at 70.46%.
- What is the recent revenue and earnings growth for ESTA?
- Looking at Establishment Labs's growth, its revenue over the trailing twelve months (TTM) was $211M. Compared to the same quarter last year (YoY), quarterly revenue grew by 45.20%, and quarterly earnings saw a YoY growth of 45.16%.
- How much of ESTA stock is held by insiders and institutions?
- Wondering who owns Establishment Labs stock? Company insiders (like executives and directors) hold about 10.16% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 102.08%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.